Chikara Nakahama
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 5
- Endocrinology top 5%
- Legionella and Acanthamoeba research 8
- Vibrio bacteria research studies 2
-
- Antibiotic Use and Resistance 3
- Microbiology top 10%
-
- Pneumonia and Respiratory Infections 5
- Respiratory viral infections research 3
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Antifungal resistance and susceptibility 2
- Co-authors
- Tetsuro MatsumotoTetsuro MurataniTakashi IdaKazunori TomonoKazunori MaebashiShinichi TeradaSho TakahataPaul H. Edelstein
- Journals
- Journal of Clinical Microbiology (2 papers)The Journal of Antibiotics (1 paper)International Journal of Antimicrobial Agents (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Chikara Nakahama
29 papers receiving 400 citations
Peers
Comparison fields: 5 of 67
- Molecular Medicine 128
- Endocrinology 120
- Applied Microbiology and Biotechnology 23
- Microbiology 54
- Microbiology 4
Countries citing papers authored by Chikara Nakahama
This map shows the geographic impact of Chikara Nakahama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chikara Nakahama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chikara Nakahama more than expected).
Fields of papers citing papers by Chikara Nakahama
This network shows the impact of papers produced by Chikara Nakahama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chikara Nakahama. The network helps show where Chikara Nakahama may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chikara Nakahama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 3 | |
| 3 | 2019 | 21 | |
| 4 | 2010 | 146 | |
| 5 | 2009 | 18 | |
| 6 | Assay of Chlamydia pneumoniae-specific IgM antibodies by ELISA method--reduction of non-specific reaction and resetting of serological criteria by measuring IgM antibodies--. | 2009 | 19 |
| 7 | 2006 | 36 | |
| 8 | Study on the Association between the Patients' Clinical Background and the Anaerobes by Data Mining In Infectious Diseases Database | 2001 | 4 |
| 9 | 1994 | 1 | |
| 10 | 1994 | 1 | |
| 11 | 1992 | 5 | |
| 12 | 1992 | 5 | |
| 13 | 1992 | 5 | |
| 14 | [Molecular diagnosis in respiratory infections]. | 1991 | 1 |
| 15 | 1990 | 3 | |
| 16 | 1989 | 2 | |
| 17 | 1985 | 1 | |
| 18 | Bacteriological and clinical studies on at-2266 | 1984 | 1 |
| 19 | 1983 | 2 | |
| 20 | [A possible case of necrotizing sarcoid-like granulomatosis (author's transl)]. | 1981 | 1 |
About Chikara Nakahama
Chikara Nakahama is a scholar working on Endocrinology, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 29 papers that have together received 413 indexed citations. Recurring topics across this work include Legionella and Acanthamoeba research (8 papers), Pneumonia and Respiratory Infections (5 papers), Antibiotic Resistance in Bacteria (5 papers), Respiratory viral infections research (3 papers), Antibiotic Use and Resistance (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Vibrio bacteria research studies (2 papers) and Antifungal resistance and susceptibility (2 papers). The work is most often cited by research in Molecular Medicine (128 citations), Endocrinology (120 citations) and Applied Microbiology and Biotechnology (23 citations). Chikara Nakahama has collaborated with scholars based in Japan and United States. Frequent co-authors include Tetsuro Matsumoto, Tetsuro Muratani, Takashi Ida, Kazunori Tomono, Kazunori Maebashi, Shinichi Terada, Sho Takahata, Paul H. Edelstein, Naoyuki Miyashita and Tadashi Ishida. Their work appears in journals such as Journal of Clinical Microbiology, The Journal of Antibiotics, International Journal of Antimicrobial Agents, Respirology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.